Effects of cadmium on bone microstructure and serum tartrate-resistant acid phosphatase 5b in male rats

Experimental Biology and Medicine

Volumn 236, Issue 11, 2011, Pages 1298-1305

  Chen, Xiao ^a   Zhu, Guoying ^a   Shao, Chunlin ^a   Jin, Taiyi ^b   Tan, Mingguang ^c   Gu, Shuzhu ^a   Zhang, Yanyan ^a   Xiao, Hanfang ^a  

^a Institute of Radiation Medicine   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF APPLIED PHYSICS   (China)

Author keywords

Bone microstructure; Bone mineral density; Cadmium; Microcomputed tomography; Tartrate resistant acid phosphatase 5b

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOLOGICAL MARKER; CADMIUM; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE INJURY; BONE LEVEL; BONE MINERAL; BONE STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; MALE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; RAT; TRABECULAR BONE; URINE LEVEL;

ACID PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CADMIUM; ISOENZYMES; MALE; OSTEOCLASTS; RATS; RATS, SPRAGUE-DAWLEY; X-RAY MICROTOMOGRAPHY;

RATTUS;

EID: 80055120595     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011104     Document Type: Article

References (42)

1. WHO/IPCS. Cadmium. Environmental Health Criteria Document 134. Geneva: WHO, 1992
2. Wang H, Zhu G, Shi Y, Weng S, Jin T, Kong Q, Nordberg GF. Influence of environmental cadmium exposure on forearm bone density. J Bone Miner Res 2003;18:553-60
3. Jin T, Nordberg GF, Ye T, Bo M, Wang H, Zhu G, Kong Q, Bernard A. Osteoporosis and renal dysfunction in general population exposed to cadmium in China. Environ Res 2004;96:353-9
4. Staessen JA, Roels HA, Emelianov D, Kuznetsova T, Thijs L, Vangronsveld J, Fagard R. Environment exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public health and environmental exposure to cadmium (PheeCad) study group. Lancet 1999;353:1140-4
5. Brzoska MM, Majewska K, Moniuszko-Jakoniuk J. Mechanical properties of femoral diaphysis and femoral neck of female rats chronically exposed to various level of cadmium. Calcif Tiss Int 2005;76:287-98
6. Brzoska MM, Majewska K, Moniuszko-Jakoniuk J. Weakness in the mechanical properties of the femur of growing female rats exposed to cadmium. Arch Toxicol 2005;79:277-88
7. Brzóska MM, Majewska K, Moniuszko-Jakoniuk J. Mineral status and mechanical properties of lumbar spine of female rats chronically exposed to various levels of cadmium. Bone 2004;34:1180-91
8. Berglund M, Akesson A, Bjellerup P, Vahter M. Metal-bone interactions. Toxicol Lett 2000;15:219-25
9. Horiguchi H, Oguma E, Sasaki S, Miyamoto K, Ikeda Y, Machida M, Kayama F. Environmental exposure to cadmium at a level insufficient to induce renal tubular dysfunction does not affect bone density among female Japanese farmers. Environ Res 2005;97:83-92
10. Alfvén T, Elinder CG, Carlsson MD, Grubb A, Hellström L, Persson B, Pettersson C, Spång G, Schütz A, Järup L. Low-level cadmium exposure and osteoporosis. J Bone Miner Res 2000;15:1579-86
11. Åkesson A, Bjellerup P, Lundh T, Lidfeldt J, Nerbrand C, Samsioe G, Skefving S, Vahter M. Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect 2006;114:830-4
12. Nawrot T, Geusens P, Nulens TS, Nemery B. Occupational cadmium exposure and calcium excretion, bone density, and osteoporosis in men. J Bone Miner Res 2010;25:1441-5
13. Iwami K, Moriyama T. Comparative effect of cadmium on osteoblastic cells and osteoclastic cells. Arch Toxicol 1993;67:352-7
14. Chen X, Zhu G, GU S, Jin T. Effects of cadmium on osteoblasts and osteoclasts in vitro. Environ Toxicol Pharmacol 2009;28:232-6
15. Wilson AK, Cerny EA, Smith BD, Wagh A, Bhattacharyya MH. Effects of cadmium on osteoclast formation and activity in vitro. Toxicol Appl Pharmacol 1996;140:451-60
16. Dalle Carbonare L, Valenti MT, Bertoldo F, Zanatta M, Zenari S, Realdi G, Lo Cascio V, Giannini S. Bone microarchitecture evaluated by histomorphometry. Micron 2005;36:609-16
17. Comelekoglu U, Yalin S, Bagis S, Ogenler O, Sahin NO, Yildiz A, Coskun B, Hatungil R, Turac A. Low-exposure cadmium is more toxic on osteoporotic rat femoral bone: mechanical, biochemical, and histopathological evaluation. Ecotoxicol Environ Safety 2007;66:267-71
18. Dalle Carbonare L, Giannini S. Bone microarchitecture as an important determinant of bone strength. J Endocrinol Invest 2004;27:99-105
19. Stein MS, Packham DK, Ebeling PR. Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 1996;28:515-22
20. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Väänänen HK. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 2000;15:1337-45
21. Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab 2006;52:499-509
22. Alatalo SL, Peng Z, Janckila AJ, Kaija H, Vihko P, Vaananen HK, Halleen JM. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum. J Bone Miner Res 2003;18:134-9
23. Rissanen JP, Suominen MI, Oksala R, Ravanti L, Kallio PJ, Halleen JM. The ratio of osteoclast activity/osteoclast number (CTX/TRACP5b) is a useful parameter in experimental rat models of osteoporosis. J Bone Miner Res 2006;21:s105
24. Chu P, Chao TY, Lin YF, Janckila AJ, Yam LT. Correlation between histomophometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. Am J Kidney Dis 2003;41:1052-9
25. Sheng ZF, Dai RC, Wu XP, Fang LN, Fan HJ, Liao EY. Regionally specific compensation for bone loss in the tibial trabeculae of estrogen-deficient rats. Acta Radiol 2007;48:531-9
26. WHO. Prevention and management of osteoporosis. WHO Technical Report 921. Geneva: WHO, 2003
27. Uriu K, Morimoto I, Kai K, Okazaki Y, Okada Y, Qie YL, Okimoto N, Kaizu K, Nakamura T, Eto S. Uncoupling between bone formation and resorption in ovariectomized rats with chronic cadmium exposure. Toxicol Appl Pharmacol 2000;164:264-72
28. Hernandez CJ, Beaupré GS, Keller TS, Carter DR. The influence of bone volume fraction and ash fraction on bone strength and modulus. Bone 2001;29:74-8
29. Mehta S, Öz O, Antich P. Bone elasticity and ultrasound velocity are affected by subtle changes in organic matrix. J Bone Miner Res 1998;13:114-9
30. Friedman AW. Important determinants of bone strength: beyond bone mineral density. J Clin Rheumatol 2006;12:70-7
31. Dempster DW. Bone microarchitecture and strength. Osteoporos Int 2003;14:s54-6
32. Legrand E, Chappard D, Pascaretti C, Duquenne M, Krebs S, Rohmer V, Basle MF, Audran M. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res 2000;15:13-9
33. Audran M, Chappard D, Legrand E, Libouban H, Baslé MF. Bone microarchitecture and bone fragility in men: DXA and histomorphometry in humans and in orchidectomized rat model. Calcif Tiss Int 2001;69:214-7
34. Jarup L, Alfven T, Persson B, Toss G, Elinder CG. Cadmium may be a risk factor for osteoporosis. Occup Environ Med 1998;5:435-9
35. Kazantzis G. Cadmium, osteoporosis and calcium metabolism. Biometals 2004;17:493-8
36. Suzuki Y, Morita I, Yamane Y, Murota S. Preventive effect of zinc agains cadmium-induced bone resorption. Toxicology 1990;62:27-34
37. Nogawa K, Kobayashi E, Yamada Y, Honda R, Kido T, Tsuritani I, Ishizaki M. Parathyroid hormone concentration in the serum of people with cadmium-induced renal damage. Int Arch Occup Environ Health 1984;54:187-93
38. Brzóska MM, Moniuszko-Jakoniuk J. Bone metabolism of male rats chronically exposed to cadmium. Toxicol Appl Pharmacol 2005;207:195-211
39. Herrmann M, Seibel MJ. The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: a comparative review. Clin Chim Acta 2008;393:57-75
40. Tähtelä R, Seppänen J, Laitinen K, Katajamäki A, Risteli J, Välimäki MJ. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide. Osteoporosis Int 2005;16:1109-16
41. Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 2002;30:886-90
42. Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel MJ, Väänänen HK. Serum Tartrate-resistant acid phosphatase is a specific and sensitive marker of bone resorption. Clin Chem 2001;47:597-600